ADMP logo

Adamis Pharmaceuticals (ADMP) CAPEX

Annual CAPEX

$680.40 K
-$543.00 K-44.38%

December 31, 2022

Summary

Performance

1-Year Change

-44.38%

3-Year Change

-76.26%

5-Year Change

-67.43%

15-Year Change

-67.43%

ADMP CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$10.00 M
ADMP annual capital expenditures is currently -93.20% below its historical high of $10.00 million

3-Year Low

$680.40 K
ADMP annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
ADMP previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
ADMP next annual earnings announcement has not yet been scheduled

OtherADMPcash flowmetrics:

Annual FCF

-$26.58 M
ADMP annual free cash flow is -$26.58 million

Annual CFO

-$25.90 M
ADMP annual cash flow from operations is -$25.90 million

Annual CFI

$3.48 M
ADMP annual cash flow from investing activities is $3.48 million

Annual CFF

$285.00 K
ADMP annual cash flow from financing activities is $285.00 thousand

Quarterly CAPEX

N/A

June 30, 2023

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

ADMP Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$10.00 M
ADMP quarterly capital expenditures is currently at an all-time high

3-Year Low

$26.90 K
ADMP quarterly capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
ADMP previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
ADMP next earnings announcement has not yet been scheduled

OtherADMPcash flowmetrics:

Quarterly FCF

-$2.57 M
ADMP quarterly free cash flow is -$2.57 million

Quarterly CFO

-$2.57 M
ADMP quarterly cash flow from operations is -$2.57 million

Quarterly CFI

$138.30 K
ADMP quarterly cash flow from investing activities is $138.30 thousand

Quarterly CFF

$800.00
ADMP quarterly cash flow from financing activities is $800.00

TTM CAPEX

N/A

June 30, 2023

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

ADMP TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$10.00 M
ADMP TTM capital expenditures is currently at an all-time high

3-Year Low

$680.40 K
ADMP TTM capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
ADMP previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
ADMP next earnings announcement has not yet been scheduled

OtherADMPcash flowmetrics:

TTM FCF

-$13.44 M
ADMP TTM free cash flow is -$13.44 million

TTM CFO

-$13.14 M
ADMP TTM cash flow from operations is -$13.14 million

TTM CFI

$1.91 M
ADMP TTM cash flow from investing activities is $1.91 million

TTM CFF

$3.01 M
ADMP TTM cash flow from financing activities is $3.01 million

ADMP CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-44.4%--
3 y3 years-76.3%--
5 y5 years-67.4%--

ADMP CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-44.4%at low
5 y5-year-76.3%at low
alltimeall time-93.2%-99.3%

Adamis Pharmaceuticals CAPEX History

DateAnnualQuarterlyTTM
Dec 2022
$680.40 K(-44.4%)
$91.50 K(-56.0%)
$680.40 K(-16.6%)
Sep 2022
-
$207.80 K(-41.3%)
$816.10 K(+7.8%)
Jun 2022
-
$354.20 K(+1216.7%)
$757.40 K(-10.3%)
Mar 2022
-
$26.90 K(-88.2%)
$844.80 K(-30.9%)
Dec 2021
$1.22 M(+74.6%)
$227.20 K(+52.4%)
$1.22 M(+26.7%)
Sep 2021
-
$149.10 K(-66.2%)
$965.70 K(+51.6%)
Jun 2021
-
$441.60 K(+8.9%)
$636.80 K(-23.4%)
Mar 2021
-
$405.50 K(-1429.5%)
$831.70 K(+18.7%)
Dec 2020
$700.50 K(-75.6%)
-$30.50 K(-83.0%)
$700.50 K(-32.2%)
Sep 2020
-
-$179.80 K(-128.2%)
$1.03 M(-34.4%)
Jun 2020
-
$636.50 K(+132.0%)
$1.57 M(+6.7%)
Mar 2020
-
$274.30 K(-9.0%)
$1.47 M(-48.5%)
Dec 2019
$2.87 M(-18.9%)
$301.50 K(-16.5%)
$2.87 M(-2.1%)
Sep 2019
-
$361.00 K(-32.9%)
$2.93 M(-34.5%)
Jun 2019
-
$538.00 K(-67.7%)
$4.47 M(-10.6%)
Mar 2019
-
$1.67 M(+357.3%)
$5.00 M(+41.4%)
Dec 2018
$3.54 M(+69.2%)
$364.30 K(-80.8%)
$3.54 M(-6.4%)
Sep 2018
-
$1.90 M(+77.7%)
$3.78 M(+37.7%)
Jun 2018
-
$1.07 M(+431.8%)
$2.74 M(+22.4%)
Mar 2018
-
$201.10 K(-66.8%)
$2.24 M(+7.3%)
Dec 2017
$2.09 M(+1625.1%)
$606.40 K(-30.1%)
$2.09 M(+31.6%)
Sep 2017
-
$867.20 K(+52.8%)
$1.59 M(+120.5%)
Jun 2017
-
$567.50 K(+1082.3%)
$719.80 K(+325.7%)
Mar 2017
-
$48.00 K(-54.0%)
$169.10 K(+39.6%)
Dec 2016
$121.10 K(-98.8%)
$104.30 K(>+9900.0%)
$121.10 K(+620.8%)
Sep 2016
-
$0.00(-100.0%)
$16.80 K(0.0%)
Jun 2016
-
$16.80 K(>+9900.0%)
$16.80 K(-99.8%)
Mar 2014
$10.00 M(>+9900.0%)
$0.00(-100.0%)
$10.00 M(0.0%)
Dec 2013
-
$10.00 M(>+9900.0%)
$10.00 M(>+9900.0%)
Mar 2010
$4900.00
$0.00(0.0%)
$4900.00(0.0%)
DateAnnualQuarterlyTTM
Dec 2009
-
$0.00(-100.0%)
$4900.00(0.0%)
Sep 2009
-
$4900.00(-107.4%)
$4900.00(-95.3%)
Dec 2005
$103.50 K(-49.3%)
-$66.50 K(-166.5%)
$103.50 K(-71.4%)
Sep 2005
-
$100.00 K(-189.3%)
$362.00 K(+34.6%)
Jun 2005
-
-$112.00 K(-161.5%)
$269.00 K(-30.3%)
Mar 2005
-
$182.00 K(-5.2%)
$386.00 K(+89.2%)
Dec 2004
$204.00 K(-43.6%)
$192.00 K(+2642.9%)
$204.00 K(+18.6%)
Sep 2004
-
$7000.00(+40.0%)
$172.00 K(-28.3%)
Jun 2004
-
$5000.00(-96.9%)
$240.00 K(-33.7%)
Dec 2003
$362.00 K(-50.6%)
$160.00 K(+113.3%)
$362.00 K(-0.5%)
Sep 2003
-
$75.00 K(+5.6%)
$364.00 K(-7.4%)
Jun 2003
-
$71.00 K(+26.8%)
$393.00 K(-46.4%)
Mar 2003
-
$56.00 K(-65.4%)
$733.00 K(0.0%)
Dec 2002
$733.00 K(+215.9%)
$162.00 K(+55.8%)
$733.00 K(+0.8%)
Sep 2002
-
$104.00 K(-74.7%)
$727.00 K(+7.1%)
Jun 2002
-
$411.00 K(+633.9%)
$679.00 K(+147.8%)
Mar 2002
-
$56.00 K(-64.1%)
$274.00 K(+18.1%)
Dec 2001
$232.00 K(+15.4%)
$156.00 K(+178.6%)
$232.00 K(-260.1%)
Sep 2001
-
$56.00 K(+833.3%)
-$144.90 K(-179.1%)
Jun 2001
-
$6000.00(-57.1%)
$183.10 K(-4.2%)
Mar 2001
-
$14.00 K(-106.3%)
$191.10 K(-5.0%)
Dec 2000
$201.10 K(-71.3%)
-$220.90 K(-157.5%)
$201.10 K(-52.3%)
Sep 2000
-
$384.00 K(+2642.9%)
$422.00 K(+1105.7%)
Jun 2000
-
$14.00 K(-41.7%)
$35.00 K(-94.4%)
Mar 2000
-
$24.00 K(>+9900.0%)
$624.00 K(-10.9%)
Dec 1999
$700.00 K(-75.0%)
$0.00(-100.0%)
$700.00 K(-78.8%)
Sep 1999
-
-$3000.00(-100.5%)
$3.30 M(-5.8%)
Jun 1999
-
$603.00 K(+503.0%)
$3.50 M(+20.8%)
Mar 1999
-
$100.00 K(-96.2%)
$2.90 M(+3.6%)
Dec 1998
$2.80 M
$2.60 M(+1200.0%)
$2.80 M(+1300.0%)
Sep 1998
-
$200.00 K
$200.00 K

FAQ

  • What is Adamis Pharmaceuticals annual capital expenditures?
  • What is the all time high annual CAPEX for Adamis Pharmaceuticals?
  • What is Adamis Pharmaceuticals annual CAPEX year-on-year change?
  • What is the all time high quarterly CAPEX for Adamis Pharmaceuticals?
  • What is the all time high TTM CAPEX for Adamis Pharmaceuticals?

What is Adamis Pharmaceuticals annual capital expenditures?

The current annual CAPEX of ADMP is $680.40 K

What is the all time high annual CAPEX for Adamis Pharmaceuticals?

Adamis Pharmaceuticals all-time high annual capital expenditures is $10.00 M

What is Adamis Pharmaceuticals annual CAPEX year-on-year change?

Over the past year, ADMP annual capital expenditures has changed by -$543.00 K (-44.38%)

What is the all time high quarterly CAPEX for Adamis Pharmaceuticals?

Adamis Pharmaceuticals all-time high quarterly capital expenditures is $10.00 M

What is the all time high TTM CAPEX for Adamis Pharmaceuticals?

Adamis Pharmaceuticals all-time high TTM capital expenditures is $10.00 M